AI assistant
Sending…
Inotiv, Inc. — Director's Dealing 2019
Apr 24, 2019
34595_dirs_2019-04-24_211e2cb8-7ed4-44f0-b8a8-bac1b6904f8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2019-04-16
Reporting Person: Sagartz Kimberly L (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-04-16 | Common Shares | J | 632475 | — | Acquired | 632475 | Direct |
Footnotes
F1: The Reporting Person owns 42.165% of the outstanding equity interests of SW Chrysalis, LLC, a Delaware limited liability company, and is its Co-President and Chief Operating Officer. On April 16, 2019, SW Chrysalis, LLC distributed all of its 1,500,000 Common Shares of the Issuer to its members pro rata in proportion to their respective equity interest percentages, in exchange for no consideration. As a result of such distribution, the Reporting Person now directly beneficially owns 632,475 Common Shares of the Issuer.
More from Inotiv, Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 10
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19